Klokman WJ - Search Results

1

[Second primary tumors in patients treated at an early age for Hodgkin's disease; consequences for the follow-up].

Aleman BM, Klokman WJ, van Leeuwen FE. Aleman BM, et al. Among authors: klokman wj. Ned Tijdschr Geneeskd. 2000 Aug 5;144(32):1517-20. Ned Tijdschr Geneeskd. 2000. PMID: 10949633 Review. Dutch.

2

Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.

van Leeuwen FE, Klokman WJ, Stovall M, Dahler EC, van't Veer MB, Noordijk EM, Crommelin MA, Aleman BM, Broeks A, Gospodarowicz M, Travis LB, Russell NS. van Leeuwen FE, et al. Among authors: klokman wj. J Natl Cancer Inst. 2003 Jul 2;95(13):971-80. doi: 10.1093/jnci/95.13.971. J Natl Cancer Inst. 2003. PMID: 12837833

3

Long-term cause-specific mortality of patients treated for Hodgkin's disease.

Aleman BM, van den Belt-Dusebout AW, Klokman WJ, Van't Veer MB, Bartelink H, van Leeuwen FE. Aleman BM, et al. Among authors: klokman wj. J Clin Oncol. 2003 Sep 15;21(18):3431-9. doi: 10.1200/JCO.2003.07.131. Epub 2003 Jul 28. J Clin Oncol. 2003. PMID: 12885835

4

Second cancer risk following Hodgkin's disease: a 20-year follow-up study.

van Leeuwen FE, Klokman WJ, Hagenbeek A, Noyon R, van den Belt-Dusebout AW, van Kerkhoff EH, van Heerde P, Somers R. van Leeuwen FE, et al. Among authors: klokman wj. J Clin Oncol. 1994 Feb;12(2):312-25. doi: 10.1200/JCO.1994.12.2.312. J Clin Oncol. 1994. PMID: 8113838

5

Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood.

van Leeuwen FE, Klokman WJ, Veer MB, Hagenbeek A, Krol AD, Vetter UA, Schaapveld M, van Heerde P, Burgers JM, Somers R, Aleman BM. van Leeuwen FE, et al. Among authors: klokman wj. J Clin Oncol. 2000 Feb;18(3):487-97. doi: 10.1200/JCO.2000.18.3.487. J Clin Oncol. 2000. PMID: 10653864

6

Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years.

Dorresteijn LD, Kappelle AC, Boogerd W, Klokman WJ, Balm AJ, Keus RB, van Leeuwen FE, Bartelink H. Dorresteijn LD, et al. Among authors: klokman wj. J Clin Oncol. 2002 Jan 1;20(1):282-8. doi: 10.1200/JCO.2002.20.1.282. J Clin Oncol. 2002. PMID: 11773180

7

Increased risk of breast cancer development after diagnosis of salivary gland tumour.

In der Maur CD, Klokman WJ, van Leeuwen FE, Tan IB, Rutgers EJ, Balm AJ. In der Maur CD, et al. Among authors: klokman wj. Eur J Cancer. 2005 Jun;41(9):1311-5. doi: 10.1016/j.ejca.2005.02.023. Eur J Cancer. 2005. PMID: 15939266

8

Late cardiotoxicity after treatment for Hodgkin lymphoma.

Aleman BM, van den Belt-Dusebout AW, De Bruin ML, van 't Veer MB, Baaijens MH, de Boer JP, Hart AA, Klokman WJ, Kuenen MA, Ouwens GM, Bartelink H, van Leeuwen FE. Aleman BM, et al. Among authors: klokman wj. Blood. 2007 Mar 1;109(5):1878-86. doi: 10.1182/blood-2006-07-034405. Epub 2006 Nov 21. Blood. 2007. PMID: 17119114 Free article.

9

Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.

van Leeuwen FE, Klokman WJ, Stovall M, Hagenbeek A, van den Belt-Dusebout AW, Noyon R, Boice JD Jr, Burgers JM, Somers R. van Leeuwen FE, et al. Among authors: klokman wj. J Natl Cancer Inst. 1995 Oct 18;87(20):1530-7. doi: 10.1093/jnci/87.20.1530. J Natl Cancer Inst. 1995. PMID: 7563187

10

Re: Smoking, treatment for Hodgkin's disease, and subsequent lung cancer risk.

van Leeuwen FE, Klokman WJ. van Leeuwen FE, et al. Among authors: klokman wj. J Natl Cancer Inst. 1996 Feb 21;88(3-4):209. doi: 10.1093/jnci/88.3-4.209. J Natl Cancer Inst. 1996. PMID: 8632496 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters